Lataa...
Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death?
Recent clinical trials indicate that approximately two-thirds of patients in New York Heart Association (NYHA) class II and III, who comprise almost 90% of patients with heart failure, die suddenly. Patients in NYHA class IV usually die of progressive heart failure. Implantation of implantable cardi...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2000
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC59608/ https://ncbi.nlm.nih.gov/pubmed/11714419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cvm-1-2-095 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|